Trials / Unknown
UnknownNCT00781716
Safety and Efficacy Study of CYPHER® Sirolimus Stent and ENDEAVOR® Zotarolimus Stent in Patients With Acute ST Elevation Myocardial Infarction (STEMI) and Analysis of Current Status of Emergency PCI Green Channel for STEMI Patients in China
Comparison of Safety and Efficacy of CYPHER® Sirolimus Stent and ENDEAVOR® Zotarolimus Stent in Patients With Acute ST Elevation Myocardial Infarction and Analysis of Current Status of Emergency PCI Green Channel for Patients With ST Elevation Myocardial Infarction in China
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,020 (estimated)
- Sponsor
- Beijing Chao Yang Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is to compare the clinical effect of CYPHER® stent and ENDEAVOR® stent in patients with acute ST elevation myocardial infarction. It also aims to analyze the current status of emergency PCI green channel (time taken from door→ hospital→ PIC sign-off→ needle→ balloon) for patients with ST elevation myocardial infarction in China.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Drug eluting coronary stent system | Cypher Sirolimus-Eluting Coronary Stent System vs Endeavor Zotarolimus-Eluting Coronary Stent System |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2011-05-01
- Completion
- 2011-05-01
- First posted
- 2008-10-29
- Last updated
- 2008-10-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00781716. Inclusion in this directory is not an endorsement.